TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(FY)May 31, 2024 | (Q6)Nov 30, 2023 | (FY)May 31, 2023 | (Q6)Nov 30, 2022 | (FY)May 31, 2022 | (Q6)Nov 30, 2021 | (FY)May 31, 2021 | (Q6)Nov 30, 2020 | (FY)May 31, 2020 | (Q6)Nov 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 72.43%2.02B | ---- | 312.34%1.17B | ---- | 66.72%-552.27M | ---- | -131.94%-1.66B | ---- | -854.19%-715.45M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -137.07%-77.41M | ---- | -185.46%-32.65M | ---- | 16.92%-11.44M | ---- | 78.94%-13.77M | ---- | -1,072.96%-65.38M | ---- |
Attributable subsidiary (profit) loss | -129.66%-3.79M | ---- | 513.74%12.76M | ---- | 60.39%-3.09M | ---- | -533.63%-7.79M | ---- | 157.73%1.8M | ---- |
Impairment and provisions: | -77.66%6.2M | ---- | 952.75%27.74M | ---- | -96.90%2.64M | ---- | 5,325.80%84.97M | ---- | 77.95%1.57M | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | --62.59M | ---- | ---- | ---- |
-Other impairments and provisions | -77.66%6.2M | ---- | 952.75%27.74M | ---- | -88.23%2.64M | ---- | 1,329.12%22.38M | ---- | --1.57M | ---- |
Revaluation surplus: | 257.98%3.35M | ---- | 76.72%-2.12M | ---- | 77.44%-9.12M | ---- | 11.57%-40.42M | ---- | -9.02%-45.71M | ---- |
-Other fair value changes | 257.98%3.35M | ---- | 76.72%-2.12M | ---- | 77.44%-9.12M | ---- | 11.57%-40.42M | ---- | -9.02%-45.71M | ---- |
Asset sale loss (gain): | -197,928.30%-1.48B | ---- | -98.36%749K | ---- | 6,029.05%45.78M | ---- | -76.98%747K | ---- | 1,129.17%3.25M | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --213K | ---- |
-Loss (gain) on sale of property, machinery and equipment | -257.81%-1.18M | ---- | -98.36%749K | ---- | 6,029.05%45.78M | ---- | -75.36%747K | ---- | 1,048.48%3.03M | ---- |
-Loss (gain) from selling other assets | ---1.48B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | 37.63%62.95M | ---- | -48.75%45.74M | ---- | -40.30%89.24M | ---- | 68.49%149.49M | ---- | 880.34%88.72M | ---- |
-Depreciation | 21.64%21.91M | ---- | -48.73%18.01M | ---- | -23.34%35.13M | ---- | 197.91%45.83M | ---- | 69.99%15.38M | ---- |
Financial expense | 40.08%2.37M | ---- | -74.68%1.69M | ---- | -55.82%6.67M | ---- | 42.77%15.1M | ---- | --10.58M | ---- |
Exchange Loss (gain) | 88.00%-9.44M | ---- | -67.88%-78.68M | ---- | -128.89%-46.87M | ---- | 321.72%162.24M | ---- | 22.67%-73.18M | ---- |
Special items | 307.03%417.37M | ---- | -29.94%102.54M | ---- | -46.84%146.35M | ---- | 129.50%275.3M | ---- | 121.24%119.96M | ---- |
Operating profit before the change of operating capital | -24.67%941.95M | ---- | 476.54%1.25B | ---- | 67.87%-332.1M | ---- | -53.37%-1.03B | ---- | -332.50%-673.85M | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -106.42%-281.39M | ---- | -2,842.35%-136.32M | ---- | ---4.63M | ---- | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | 30.93%-125.86M | ---- | -895.48%-182.2M | ---- | -309.99%-18.3M | ---- | 178.86%8.72M | ---- | -225.73%-11.05M | ---- |
Accounts payable increase (decrease) | 28.81%616.15M | ---- | 292.98%478.36M | ---- | -537.95%-247.88M | ---- | -48.46%56.6M | ---- | 46.74%109.82M | ---- |
prepayments (increase)decrease | -352.10%-76.76M | ---- | -190.84%-16.98M | ---- | -137.86%-5.84M | ---- | 1,214.66%15.42M | ---- | 108.11%1.17M | ---- |
Special items for working capital changes | -178.27%-81.42M | ---- | 133.17%104.02M | ---- | -1,018.00%-313.59M | ---- | -5.77%34.16M | ---- | -53.31%36.25M | ---- |
Cash from business operations | -33.70%992.68M | ---- | 262.34%1.5B | ---- | -0.40%-922.34M | ---- | -70.86%-918.62M | ---- | -2,438.85%-537.65M | ---- |
Other taxs | 29.72%-172.1M | ---- | -143,100.58%-244.87M | ---- | 69.24%-171K | ---- | -239.70%-556K | ---- | 106.99%398K | ---- |
Interest received - operating | 197.20%35.5M | ---- | 168.97%11.95M | ---- | -19.25%4.44M | ---- | -65.24%5.5M | ---- | 633.81%15.82M | ---- |
Special items of business | ---- | -10.50%481.11M | ---- | 162.12%537.58M | ---- | -114.61%-865.35M | ---- | -655.74%-403.23M | ---- | -250.64%-53.36M |
Net cash from operations | -32.29%856.09M | -10.50%481.11M | 237.73%1.26B | 162.12%537.58M | -0.48%-918.07M | -114.61%-865.35M | -75.22%-913.68M | -655.74%-403.23M | -2,010.13%-521.43M | -250.64%-53.36M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 202.98%43.31M | 1,901.54%16.91M | 161.05%14.3M | -26.14%845K | -88.71%5.48M | -97.55%1.14M | 501.74%48.52M | 493.64%46.77M | --8.06M | -11.38%7.88M |
Restricted cash (increase) decrease | ---- | ---35K | ---- | ---- | ---- | ---7.75M | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | -590.09%-450.19M | -6,222.38%-188.15M | 80.46%-65.24M | 99.11%-2.98M | -131.30%-333.9M | -131.50%-333.9M | 174.79%1.07B | 160.31%1.06B | ---1.43B | ---1.76B |
Sale of fixed assets | 692.08%1.9M | 0.00%3K | -97.50%240K | -99.92%3K | 8,803.70%9.62M | 12,056.67%3.65M | 68.75%108K | -43.40%30K | 72.97%64K | 165.00%53K |
Purchase of fixed assets | -179.55%-35.86M | -298.61%-18.95M | 36.92%-12.83M | 74.63%-4.76M | 82.79%-20.33M | 68.61%-18.74M | -47.95%-118.13M | -79.01%-59.71M | -283.31%-79.84M | -229.68%-33.36M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | 97.85%-214K | 97.41%-213K | ---9.96M | ---8.22M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --24K | ---- |
Recovery of cash from investments | 75.17%3.01B | 83.89%1.48B | -27.99%1.72B | -46.34%803.06M | -32.85%2.38B | 543.98%1.5B | 215.00%3.55B | -33.60%232.41M | 12.66%1.13B | -7.89%350M |
Cash on investment | -34.40%-3.21B | -36.46%-1.58B | -15.41%-2.39B | -1.67%-1.16B | 46.70%-2.07B | -59.62%-1.14B | -268.43%-3.89B | -225.88%-712.01M | -9.44%-1.06B | 45.38%-218.49M |
Other items in the investment business | --849.5M | ---- | ---- | ---- | 110.18%196K | ---634K | -184.07%-1.93M | ---- | --2.29M | ---- |
Net cash from investment operations | 127.49%202.75M | 19.23%-290.23M | -2,696.91%-737.55M | -9,247.35%-359.31M | -104.00%-26.37M | -99.31%3.93M | 145.98%659.11M | 134.18%567.18M | -9,126.32%-1.43B | -7,725.63%-1.66B |
Net cash before financing | 100.96%1.06B | 7.07%190.88M | 155.79%526.88M | 120.70%178.27M | -271.01%-944.44M | -625.41%-861.42M | 86.98%-254.56M | 109.57%163.95M | -22,035.81%-1.95B | -12,151.90%-1.71B |
Cash flow from financing activities | ||||||||||
Issuing shares | -68.25%27.97M | -82.33%6.34M | 7,758.16%88.09M | 3,099.46%35.87M | -99.93%1.12M | -81.67%1.12M | 5,994.39%1.52B | -63.83%6.11M | -98.58%24.99M | -87.22%16.9M |
Absorb investment income | --400K | ---- | ---- | ---- | --10K | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | 10.50%-835K | ---132K | 98.53%-933K | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,498.66%1.31B | ---94M | ---94M |
Net cash from financing operations | -126.54%-14.77M | -164.07%-15.74M | 222.57%55.64M | 181.72%24.56M | -103.21%-45.4M | -102.37%-30.06M | 1,142.28%1.41B | 1,325.71%1.27B | -107.96%-135.49M | -179.37%-103.44M |
Effect of rate | 51.44%53.25M | -89.03%4.76M | 98.48%35.16M | 3,132.96%43.43M | 114.98%17.72M | 97.58%-1.43M | -262.18%-118.27M | -267.80%-59.21M | -22.87%72.93M | -39.10%35.28M |
Net Cash | 79.23%1.04B | -13.65%175.14M | 158.85%582.53M | 122.75%202.84M | -185.51%-989.84M | -162.26%-891.48M | 155.38%1.16B | 178.83%1.43B | -223.42%-2.09B | -1,356.68%-1.82B |
Begining period cash | 112.83%1.17B | 112.83%1.17B | -63.97%547.45M | -63.97%547.45M | 216.41%1.52B | 216.41%1.52B | -80.77%480.25M | -80.77%480.25M | 252.05%2.5B | 252.05%2.5B |
Cash at the end | 94.18%2.26B | 69.46%1.35B | 112.83%1.17B | 26.66%793.71M | -63.97%547.45M | -66.18%626.65M | 216.41%1.52B | 158.58%1.85B | -80.77%480.25M | -21.43%716.53M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.